Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEW YORK and WALTHAM, Mass., April 05, 2024 (GLOBE NEWSWIRE) — Dianthus Therapeutics, Inc. (“Dianthus”), a clinical-stage biotechnology company dedicated […]
Triumph Financial Announces Schedule for First Quarter 2024 Earnings Release and Conference Call
DALLAS, April 05, 2024 (GLOBE NEWSWIRE) — Triumph Financial, Inc. (Nasdaq: TFIN) today announced that it expects to release its […]
NeuBase Therapeutics Announces Receipt of Notice from Nasdaq
PITTSBURGH, April 05, 2024 (GLOBE NEWSWIRE) — NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“NeuBase” or the “Company”) today reported that it […]
Sonder Holdings Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K
SAN FRANCISCO, April 05, 2024 (GLOBE NEWSWIRE) — Sonder Holdings Inc. (NASDAQ: SOND, “Sonder” or the “Company”) today announced that […]
23andMe to Present Data on Two Clinical Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024
23ME-01473, antibody targeting ULBP6: Data will be presented on the discovery and biology of ULBP6, and the potential to restore […]
Kernel Group Holdings, Inc. Extends Period to Consummate Initial Business Combination
New York, April 05, 2024 (GLOBE NEWSWIRE) — Kernel Group Holdings, Inc. (NASDAQ: KRNLU, KRNL, KRNLW) (“KRNL” or the “Company”), […]
First Hawaiian to Report First Quarter 2024 Financial Results on April 26, 2024
HONOLULU, April 05, 2024 (GLOBE NEWSWIRE) — First Hawaiian, Inc. (NASDAQ: FHB) announced today that it plans to release its […]
Churchill Downs Incorporated Opens Terre Haute Casino Resort in Terre Haute, Indiana
Casino Floor and Food & Beverage Amenities Open to the Public122-Room Luxury Hotel to Open May 15 LOUISVILLE, Ky., April […]
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
WESTLAKE VILLAGE, Calif., April 05, 2024 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing […]
USCB Financial Holdings, Inc. to Announce First Quarter 2024 Results
MIAMI, April 05, 2024 (GLOBE NEWSWIRE) — USCB FINANCIAL HOLDINGS, INC. (the “Company”) (NASDAQ: USCB) will report financial results for […]
